Teva Pharmaceutical Industries Limited (VIE:TEVA)

Market Cap	37.36B +95.0%
Revenue (ttm)	15.16B +4.1%
Net Income	617.96M
EPS	0.53
Shares Out	n/a
PE Ratio	60.45
Forward PE	12.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	31.50
Previous Close	31.30
Day's Range	31.30 - 31.60
52-Week Range	15.50 - 32.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2026

About VIE:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 32,008
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 14, 2026

Data Sources Report a data error